SEC Filings

Filing date	Description	Form	Filing Group	Issuer	View
View HTML 0000899243-19-019526.pdf 0000899243-19-019526.rtf	Jul 12, 2019	Statement of changes in beneficial ownership of securities	4	3,4,5	Eidos Therapeutics, Inc.
View HTML 0001193125-19-190741.pdf 0001193125-19-190741.rtf 0001193125-19-190741.xls	Jul 09, 2019	An amendment to a SC 13D filing	SC 13D/A	3,4,5	Eidos Therapeutics, Inc.
View HTML 0000899243-19-019337.pdf 0000899243-19-019337.rtf	Jul 08, 2019	Statement of changes in beneficial ownership of securities	4	3,4,5	Eidos Therapeutics, Inc.
View HTML 0000899243-19-019339.pdf 0000899243-19-019339.rtf	Jul 08, 2019	Statement of changes in beneficial ownership of securities	4	3,4,5	Eidos Therapeutics, Inc.
View HTML 0000899243-19-019342.pdf 0000899243-19-019342.rtf	Jul 08, 2019	Statement of changes in beneficial ownership of securities	4	3,4,5	Eidos Therapeutics, Inc.
View HTML 0000899243-19-019343.pdf 0000899243-19-019343.rtf	Jul 08, 2019	Statement of changes in beneficial ownership of securities	4	3,4,5	Eidos Therapeutics, Inc.
View HTML 0000899243-19-018521.pdf 0000899243-19-018521.rtf	Jun 28, 2019	Statement of changes in beneficial ownership of securities	4	3,4,5	Eidos Therapeutics, Inc.
View HTML 0001193125-19-174717.pdf 0001193125-19-174717.rtf 0001193125-19-174717.xls	Jun 17, 2019	Report of unscheduled material events or corporate event	8-K	Current Reports	Eidos Therapeutics, Inc.
View HTML 0000899243-19-016951.pdf 0000899243-19-016951.rtf	Jun 13, 2019	Statement of changes in beneficial ownership of securities	4	3,4,5	Eidos Therapeutics, Inc.
View HTML 0000899243-19-016952.pdf 0000899243-19-016952.rtf	Jun 13, 2019	Statement of changes in beneficial ownership of securities	4	3,4,5	Eidos Therapeutics, Inc.